Outcomes of preoperative angiotensin-converting enzyme inhibitor therapy in patients undergoing isolated coronary artery bypass grafting

American Journal of Cardiology

Volumn 110, Issue 7, 2012, Pages 919-923

  Bandeali, Salman J ^a   Kayani, Waleed T ^a   Lee, Vei Vei ^c   Pan, Wei ^d   Elayda, Mac Arthur A ^c   Nambi, Vijay ^a   Jneid, Hani M ^a,b   Alam, Mahboob ^e   Wilson, James M ^c   Birnbaum, Yochai ^a   Ballantyne, Christie M ^a   Virani, Salim S ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c ST LUKE S EPISCOPAL HOSPITAL   (United States)

^d TEXAS HEART INSTITUTE   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DRUG USE; FEMALE; HEART ATRIUM FIBRILLATION; HEART EJECTION FRACTION; HEART INFARCTION; HOSPITALIZATION; HUMAN; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; STROKE; TREATMENT OUTCOME;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; FEMALE; FOLLOW-UP STUDIES; HOSPITAL MORTALITY; HUMANS; INCIDENCE; MALE; MIDDLE AGED; ODDS RATIO; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE PERIOD; PREOPERATIVE CARE; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TEXAS; TREATMENT OUTCOME;

EID: 84866072857     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2012.05.021     Document Type: Article

References (28)

1. S. Yusuf, P. Sleight, J. Pogue, J. Bosch, R. Davies, G. Dagenais Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients The Heart Outcomes Prevention Evaluation Study Investigators N Engl J Med 342 2000 145 153
2. K.M. Fox EURopean trial On reduction of cardiac events with Perindopril in stable coronary Artery disease Investigators Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study) Lancet 362 2003 782 788 (Pubitemid 37093919)
3. ACE Inhibitor Myocardial Infarction Collaborative Group Indications for ACE inhibitors in the early treatment of acute myocardial infarction: systematic overview of individual data from 100,000 patients in randomized trials Circulation 97 1998 2202 2212
4. M.A. Pfeffer, E. Braunwald, L.A. Moyé, L. Basta, E.J. Brown Jr, T.E. Cuddy, B.R. Davis, E.M. Geltman, S. Goldman, G.C. Flaker, M. Klein, G.A. Lamas, M. Packer, J. Rouleau, J.L. Rouleau, J. Rutherford, J.H. Wertheimer, C.M. Hawkins Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction Results of the Survival and Ventricular Enlargement Trial. The SAVE investigators N Engl J Med 327 1992 669 677
5. M. Oosterga, A.A. Voors, Y.M. Pinto, H. Buikema, J.G. Grandjean, J.H. Kingma, H.J. Crijns, W.H. van Gilst Effects of quinapril on clinical outcome after coronary artery bypass grafting (The QUO VADIS Study) QUinapril on Vascular Ace and Determinants of Ischemia Am J Cardiol 87 2001 542 546 (Pubitemid 32178447)
6. M.Y. Rady, T. Ryan The effects of preoperative therapy with angiotensin-converting enzyme inhibitors on clinical outcome after cardiovascular surgery Chest 114 1998 487 494 (Pubitemid 28387528)
7. J.L. Rouleau, W.J. Warnica, R. Baillot, P.J. Block, S. Chocron, D. Johnstone, M.G. Myers, C.D. Calciu, S. Dalle-Ave, P. Martineau, C. Mormont, W.H. van Gilst IMAGINE (Ischemia Management with Accupril post-bypass Graft via Inhibition of the coNverting Enzyme) Investigators Effects of angiotensin-converting enzyme inhibition in low-risk patients early after coronary artery bypass surgery Circulation 117 2008 24 31 (Pubitemid 350291178)
8. S.S. Virani, V. Nambi, V.V. Lee, M.A. Elayda, W. Pan, L.A. Petersen, J.M. Wilson, J.T. Willerson, C.M. Ballantyne Obesity: an independent predictor of in-hospital postoperative renal insufficiency among patients undergoing cardiac surgery? Tex Heart Inst J 36 2009 540 545
9. M. Alam, S. Siddiqui, V.V. Lee, M.A. Elayda, V. Nambi, E.Y. Yang, H.M. Jneid, J.M. Wilson, C.M. Ballantyne, S.S. Virani Isolated coronary artery bypass grafting in obese individuals: a propensity matched analysis of outcomes Circ J 75 2011 1378 1385
10. W.M. Weightman, N.M. Gibbs, M.R. Sheminant, E.G. Whitford, B.D. Mahon, M.A. Newman Drug therapy before coronary artery surgery: nitrates are independent predictors of mortality and beta-adrenergic blockers predict survival Anesth Analg 88 1999 286 291 (Pubitemid 29070184)
11. A. Miceli, R. Capoun, C. Fino, P. Narayan, A.J. Bryan, G.D. Angelini, M. Caputo Effects of angiotensin-converting enzyme inhibitor therapy on clinical outcome in patients undergoing coronary artery bypass grafting J Am Coll Cardiol 54 2009 1778 1784
12. P.M. Reilly, G.B. Bulkley Vasoactive mediators and splanchnic perfusion Crit Care Med 21 1993 S55 S68
13. J. Boldt, E. Schindler, K. Härter, G. Görlach, G. Hempelmann Influence of intravenous administration of angiotensin-converting enzyme inhibitor enalaprilat on cardiovascular mediators in cardiac surgery patients Anesth Analg 80 1995 480 485
14. E.M. Lonn, S. Yusuf, P. Jha, T.J. Montague, K.K. Teo, C.R. Benedict, B. Pitt Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection Circulation 90 1994 2056 2069 (Pubitemid 24320959)
15. H.L. Lazar All coronary artery bypass graft surgery patients will benefit from angiotensin-converting enzyme inhibitors Circulation 117 2008 6 8 (Pubitemid 350291174)
16. N.J. Brown, M.A. Agirbasli, G.H. Williams, W.R. Litchfield, D.E. Vaughan Effect of activation and inhibition of the renin-angiotensin system on plasma PAI-1 Hypertension 32 1998 965 971 (Pubitemid 29001421)
17. M. Miyazaki, H. Sakonjo, S. Takai Anti-atherosclerotic effects of an angiotensin converting enzyme inhibitor and an angiotensin II antagonist in cynomolgus monkeys fed a high-cholesterol diet Br J Pharmacol 128 1999 523 529 (Pubitemid 29504739)
18. X. Sun, S.W. Boyce, D.L. Herr, P.C. Hill, L. Zhang, P.J. Corso, E. Haile, A.T. Lee, R.E. Molyneaux Is vasoplegic syndrome more prevalent with open-heart procedures compared with isolated on-pump CABG surgery? Cardiovasc Revasc Med 12 2011 203 209
19. G.W. Fischer, M.A. Levin Vasoplegia during cardiac surgery: current concepts and management Semin Thorac Cardiovasc Surg 22 2010 140 144
20. K.J. Tuman, R.J. McCarthy, C.J. O'Connor, W.E. Holm, A.D. Ivankovich Angiotensin-converting enzyme inhibitors increase vasoconstrictor requirements after cardiopulmonary bypass Anesth Analg 80 1995 473 479
21. P. Arora, S. Rajagopalam, R. Ranjan, H. Kolli, M. Singh, R. Venuto, J. Lohr Preoperative use of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers is associated with increased risk for acute kidney injury after cardiovascular surgery Clin J Am Soc Nephrol 3 2008 1266 1273
22. E. Shantsila, T. Watson, G.Y. Lip Atrial fibrillation post-cardiac surgery: changing perspectives Curr Med Res Opin 22 2006 1437 1441 (Pubitemid 44297422)
23. S.R. Ommen, J.A. Odell, M.S. Stanton Atrial arrhythmias after cardiothoracic surgery N Engl J Med 336 1997 1429 1434 (Pubitemid 27208603)
24. C.W. Hogue Jr, L.L. Creswell, D.D. Gutterman, L.A. Fleisher American College of Chest Physicians Epidemiology, mechanisms, and risks: American College of Chest Physicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery Chest 128 2005 9S 16S (Pubitemid 41134235)
25. G. Radaelli, L.C. Bodanese, J.C. Guaragna, A.P. Borges, M.A. Goldani, J.B. Petracco, J.da C. Piccoli Jda, L.C. Albuquerque The use of inhibitors of angiotensin-converting enzyme and its relation to events in the postoperative period of CABG Rev Bras Cir Cardiovasc 26 2011 373 379
26. M.B. Jibrini, J. Molnar, R.R. Arora Prevention of atrial fibrillation by way of abrogation of the renin-angiotensin system: a systematic review and meta-analysis Am J Ther 15 2008 36 43 (Pubitemid 351161180)
27. K. Anand, A.N. Mooss, T.T. Hee, S.M. Mohiuddin Meta-analysis: inhibition of renin-angiotensin system prevents new-onset atrial fibrillation Am Heart J 152 2006 217 222 (Pubitemid 44093401)
28. C.M. White, J. Kluger, K. Lertsburapa, O. Faheem, C.I. Coleman Effect of preoperative angiotensin converting enzyme inhibitor or angiotensin receptor blocker use on the frequency of atrial fibrillation after cardiac surgery: a cohort study from the atrial fibrillation suppression trials II and III Eur J Cardiothorac Surg 31 2007 817 820